5 completed, 1 terminated. 3 Phase 3, 1 Phase 1, 1 Phase 2, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 3 |
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
| Phase 4 | 1 | Terminated 1 |
Follow Avandamet: new trials by email Literature Review of Avandamet trials Research Report on Avandamet
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Impact of Obesity and Obesity Treatments on Breast Cancer Exemestane, Avandamet - Breast Cancer | Phase 1 | Completed | M.D. Anderson Cancer Center | 25 | 2009-07-01 | 2016-02-19 |
| EMPOWIR:Enhance the Metabolic Profile of Women With Insulin Resistance metformin and rosiglitazone - Hyperinsulinemia, Insulin Resistance | Phase 2 | Completed | New York Medical College | 46 | 2008-01-01 | 2014-03-28 |
| Rosiglitazone and Metformin: Outcomes Trial in Nondiabetic Patients With Stable Coronary Syndromes (Romance) Pilot Study AVANDAMET - Coronary Artery Disease | Phase 4 | Terminated | Intermountain Health Care, Inc. | 200 | 2006-06-01 | 2011-03-17 |
| Avandia™ + Amaryl™ or Avandamet™ Compared With Metformin (AVALANCHE™ Study) Avandamet, Avandia and Amaryl, Metformin - Type 2 Diabetes Mellitus | Phase 3 | Completed | Canadian Heart Research Centre | 391 | 2005-09-01 | 2013-04-17 |
| A Lifestyle and Combination Medication Therapy Diabetes Prevention Study Avandamet [Rosiglitazone 2mg/Metformin 500mg] BID - Impaired Glucose Tolerance, Diabetes | Phase 3 | Completed | Samuel Lunenfeld Research Institute, Mount Sinai Hospital | 207 | 2004-06-01 | 2012-05-24 |
| AVANDAMET Versus Metformin And Sulphonylurea In People With Poorly Controlled Type 2 Diabetes metformin, sulphonylurea, Avandamet - Non-Insulin-Dependent Diabetes Mellitus | Phase 3 | Completed | GlaxoSmithKline | 544 | 2004-02-01 | 2009-05-18 |
Diabetes Mellitus, Type 2 (2) · Obesity (2) · Overweight (2) · Breast Neoplasms (1) · Coronary Artery Disease (1) · Diabetes Mellitus (1) · Glucose Intolerance (1) · Hyperinsulinism (1) · Inflammation (1) · Insulin Resistance (1)
Canadian Heart Research Centre (1) · GlaxoSmithKline (1) · Intermountain Health Care, Inc. (1) · M.D. Anderson Cancer Center (1) · New York Medical College (1) · Samuel Lunenfeld Research Institute, Mount Sinai Hospital (1)
United States (3) · Canada (2) · Belgium (1) · France (1) · Germany (1) · Ireland (1) · Italy (1) · Lithuania (1) · Mexico (1) · Netherlands (1) · Spain (1) · Switzerland (1) · United Kingdom (1)
Bernard Zinman, MD (1) · Francisco J. Esteva, MD, PhD (1) · Harriette R Mogul, MD MPH (1) · Joseph B Muhlestein, MD (1) · Stewart Harris, MD (1)